{"id":"https://openalex.org/W2158778171","doi":"https://doi.org/10.1186/1475-2840-10-22","title":"Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes","display_name":"Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes","alternate_titles":[],"publication_year":2011,"publication_date":"2011-03-16","ids":{"openalex":"https://openalex.org/W2158778171","doi":"https://doi.org/10.1186/1475-2840-10-22","mag":"2158778171","pmid":"https://pubmed.ncbi.nlm.nih.gov/21410975","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3070629"},"language":"en","primary_location":{"id":"doi:10.1186/1475-2840-10-22","doi":"https://doi.org/10.1186/1475-2840-10-22","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1475-2840-10-22","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/1475-2840-10-22","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2158778171"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/1475-2840-10-22","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081205041","display_name":"Robert E. Ratner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281094","display_name":"MedStar Health Research Institute","ror":"https://ror.org/03vny0n12","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405281094","https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Ratner","raw_affiliation_strings":["MedStar Health Research Institute, Hyattsville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedStar Health Research Institute, Hyattsville, MD, USA","institution_ids":["https://openalex.org/I4405281094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111694431","display_name":"Jenny Han","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jenny Han","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036735551","display_name":"Dawn Nicewarner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dawn Nicewarner","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000166921","display_name":"Irina Yushmanova","orcid":"https://orcid.org/0009-0006-1872-8093","observed_orcids":["https://orcid.org/0009-0006-1872-8093","https://orcid.org/0000-0001-9755-1893"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Irina Yushmanova","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058778822","display_name":"Byron J. Hoogwerf","orcid":"https://orcid.org/0000-0001-6014-4151","observed_orcids":["https://orcid.org/0000-0001-6014-4151"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Byron J Hoogwerf","raw_affiliation_strings":["Eli Lilly and Company and LillyUSA, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company and LillyUSA, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113725447","display_name":"Larry Zaiqian Shen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Larry Shen","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc, San Diego, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113725447"],"corresponding_institution_ids":[],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":16.1009,"has_fulltext":true,"cited_by_count":160,"citation_normalized_percentile":{"value":0.995338,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"10","issue":"1","first_page":"22","last_page":"22"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide-twice-daily","display_name":"exenatide twice daily","score":0.9390000104904175},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8849999904632568},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.9959999918937683},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9919999837875366},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.7960000038146973},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9890000224113464},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.4580000042915344},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9200537204742432},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9008612036705017},{"id":"https://openalex.org/C555175668","wikidata":"https://www.wikidata.org/wiki/Q539690","display_name":"Angiology","level":2,"score":0.7401169538497925},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6635067462921143},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6290164589881897},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5262707471847534},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5209447145462036},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36739352345466614},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.23773646354675293}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/1475-2840-10-22","doi":"https://doi.org/10.1186/1475-2840-10-22","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1475-2840-10-22","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/1475-2840-10-22","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3070629","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3070629/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Diabetol","raw_type":"Text"},{"id":"pmid:21410975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21410975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular diabetology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:65d9f993f93744d490ce4fe428479c07","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/65d9f993f93744d490ce4fe428479c07","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cardiovascular Diabetology, Vol 10, Iss 1, p 22 (2011)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.291.8333","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.291.8333","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/49/77/Cardiovasc_Diabetol_2011_Mar_16_10_22.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1186/1475-2840-10-22","doi":"https://doi.org/10.1186/1475-2840-10-22","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1475-2840-10-22","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/1475-2840-10-22","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2158778171.pdf","grobid_xml":"https://content.openalex.org/works/W2158778171.grobid-xml"},"referenced_works_count":81,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W172609984","https://openalex.org/W1526927233","https://openalex.org/W1752045965","https://openalex.org/W1925000895","https://openalex.org/W1968315455","https://openalex.org/W1976287166","https://openalex.org/W1977952802","https://openalex.org/W1980086124","https://openalex.org/W1981183973","https://openalex.org/W1981612300","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1996729304","https://openalex.org/W1998418707","https://openalex.org/W1998717083","https://openalex.org/W1999843320","https://openalex.org/W2001031717","https://openalex.org/W2004083442","https://openalex.org/W2006504598","https://openalex.org/W2011779102","https://openalex.org/W2026228390","https://openalex.org/W2028272916","https://openalex.org/W2031723890","https://openalex.org/W2032451413","https://openalex.org/W2033186049","https://openalex.org/W2033892901","https://openalex.org/W2035105326","https://openalex.org/W2035362870","https://openalex.org/W2045753702","https://openalex.org/W2050445438","https://openalex.org/W2050826565","https://openalex.org/W2058922633","https://openalex.org/W2062883844","https://openalex.org/W2063400466","https://openalex.org/W2070710390","https://openalex.org/W2076573528","https://openalex.org/W2076679703","https://openalex.org/W2078241682","https://openalex.org/W2085912144","https://openalex.org/W2093738306","https://openalex.org/W2108596571","https://openalex.org/W2108646121","https://openalex.org/W2110664743","https://openalex.org/W2110725041","https://openalex.org/W2111765225","https://openalex.org/W2111825025","https://openalex.org/W2114978217","https://openalex.org/W2120431951","https://openalex.org/W2120822075","https://openalex.org/W2123946565","https://openalex.org/W2127125241","https://openalex.org/W2129377335","https://openalex.org/W2131278438","https://openalex.org/W2131490500","https://openalex.org/W2132017042","https://openalex.org/W2134141467","https://openalex.org/W2134760433","https://openalex.org/W2139611060","https://openalex.org/W2142400535","https://openalex.org/W2149460582","https://openalex.org/W2149689944","https://openalex.org/W2154595662","https://openalex.org/W2156133857","https://openalex.org/W2157869836","https://openalex.org/W2158666727","https://openalex.org/W2162934281","https://openalex.org/W2166089332","https://openalex.org/W2166180770","https://openalex.org/W2170271198","https://openalex.org/W2170606300","https://openalex.org/W2171294019","https://openalex.org/W2172488527","https://openalex.org/W2188846692","https://openalex.org/W2337454357","https://openalex.org/W2599408064","https://openalex.org/W2769264260","https://openalex.org/W2798494090","https://openalex.org/W3198570063","https://openalex.org/W4242344507","https://openalex.org/W4246764494"],"related_works":["https://openalex.org/W2142400535","https://openalex.org/W7034027548","https://openalex.org/W2171136089","https://openalex.org/W2772282769","https://openalex.org/W4321748616","https://openalex.org/W2936529889","https://openalex.org/W2809598394","https://openalex.org/W2888943767"],"abstract_inverted_index":{"UNLABELLED:":[0],"It":[1],"is":[2],"important":[3],"for":[4,8,35,93],"patients":[5,39,111,243,259],"that":[6,156,240,242],"treatments":[7],"diabetes":[9,43,102],"not":[10,44,162,178],"increase":[11,163],"cardiovascular":[12,270],"(CV)":[13],"risk.":[14],"The":[15,138,221],"objective":[16],"of":[17,27,62,101,114,191,205,211,223,230,235],"this":[18,166],"analysis":[19,234],"was":[20,54,168],"to":[21,56,180,197,252],"examine":[22],"retrospectively":[23,187],"the":[24,58,149,175,202,208],"CV":[25,63,123,164,182,206,255],"safety":[26],"exenatide":[28,66,157,246],"BID,":[29],"a":[30,69,189,216,231,236,254],"GLP-1":[31,266],"receptor":[32,267],"agonist":[33],"approved":[34],"treating":[36],"hyperglycemia":[37],"in":[38],"with":[40,47,65,75,112,228,245,261],"type":[41],"2":[42],"adequately":[45],"controlled":[46],"diet":[48],"and":[49,99,135,215],"exercise.":[50],"Individual":[51],"participant":[52],"data":[53],"pooled":[55,70],"assess":[57,181],"relative":[59],"risk":[60],"(RR)":[61],"events":[64,124,184],"BID":[67],"versus":[68],"comparator":[71,219],"(PC)":[72],"group":[73],"treated":[74,244,260],"either":[76],"placebo":[77],"or":[78],"insulin":[79],"from":[80,87,188],"12":[81],"controlled,":[82],"randomized,":[83],"clinical":[84],"trials":[85,176,212],"ranging":[86],"12-52":[88],"weeks.":[89],"Mean":[90],"baseline":[91],"values":[92],"HbA1c":[94],"(8.33-8.38%),":[95],"BMI":[96],"(31.3-31.5":[97],"kg/m2),":[98],"duration":[100,210],"(8":[103],"y)":[104],"were":[105,177,185,249,258],"similar":[106],"between":[107],"groups.":[108],"Trials":[109],"included":[110,126,201],"histories":[113],"microvascular":[115],"and/or":[116],"macrovascular":[117],"disease.":[118],"Customized":[119],"primary":[120],"major":[121],"adverse":[122],"(MACE)":[125],"stroke,":[127],"myocardial":[128],"infarction,":[129],"cardiac":[130],"mortality,":[131],"acute":[132],"coronary":[133],"syndrome,":[134],"revascularization":[136],"procedures.":[137],"Primary":[139],"MACE":[140],"RR":[141],"(0.7;":[142],"95%":[143],"CI":[144],"0.38,":[145],"1.31),":[146],"calculated":[147],"by":[148,153,194],"Mantel-Haenszel":[150],"method":[151],"(stratified":[152],"study),":[154],"suggested":[155],"use":[158],"(vs.":[159],"PC)":[160],"did":[161],"risk;":[165],"result":[167],"consistent":[169,227],"across":[170],"multiple":[171],"analytic":[172],"methods.":[173],"Because":[174],"designed":[179],"outcomes,":[183],"identified":[186],"list":[190],"preferred":[192],"terms":[193],"physicians":[195],"blinded":[196],"treatment.":[198],"Other":[199],"limitations":[200],"low":[203],"number":[204],"events,":[207],"short":[209],"(\u22641":[213],"y),":[214],"single":[217],"active":[218],"(insulin).":[220],"results":[222],"these":[224],"analyses":[225],"are":[226],"those":[229],"recent":[232],"retrospective":[233],"large":[237],"insurance":[238],"database":[239],"found":[241],"twice":[247],"daily":[248],"less":[250],"likely":[251],"have":[253],"event":[256],"than":[257],"other":[262],"glucose-lowering":[263],"therapies.":[264],"KEYWORDS:":[265],"agonist,":[268],"diabetes,":[269],"safety.":[271]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2158778171","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":26},{"year":2012,"cited_by_count":28}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
